Semaglutide Therapy Semaglutide Therapy
1-855-551-1452
    • Home
    • Semaglutide Therapy
    • Why Us
      • Why Us
      • Semaglutide new weight loss drug injection
      • FAQs
    • Testimonials
    • News
    • Contact
      • Contact Us
      • Semaglutide Therapy Texas
      • FREE CONSULTATION
    • Home
    • Semaglutide Therapy
    • Why Us
      • Why Us
      • Semaglutide new weight loss drug injection
      • FAQs
    • Testimonials
    • News
    • Contact
      • Contact Us
      • Semaglutide Therapy Texas
      • FREE CONSULTATION
    • Home
    • Articles
    • Clinical data shows weight loss in patients with overweight or obesity following administration of Semaglutide

    Articles

    30 Nov

    Clinical data shows weight loss in patients with overweight or obesity following administration of Semaglutide

    • By Semaglutide Therapy
    • In Articles

    Obesity is a medical problem that increases the risk of other health issues, such as diabetes, high blood pressure, heart disease and various cancers. Body Mass Index (BMI) is often used to diagnose obesity. A person with BMI of 25.0-29.9 is considered overweight and a person with BMI of 30.0 and higher is considered obese. The goal in treating overweight and obesity is to achieve a normal BMI of 18.5-24.9, which will improve the person’s overall health and reduce the risks associated with excess of weight.

    Dietary changes which include cutting calories and consuming healthier meals, coupled with exercise, are recommended to treat obesity and overweight. However, along with those changes, using weight loss medications such as Semaglutide may help those struggling to lose weight. 

    Semaglutide is approved by the FDA to treat type 2 diabetes. In June 2021, the FDA approved subcutaneous Semaglutide for long-term weight management, with doses of 1.7 mg and 2.4 mg once weekly. It is the first approved drug for chronic weight management in adults with general obesity or overweight since 2014 and it is prescribed and administrated by a healthcare professional. 

    But how effective is the treatment with Semaglutide on weight loss?  

    Scientists were looking into this question by conducting clinical trials examining the effect of Semaglutide on weight loss, for example, The Treatment Effect in People With Obesity (STEP) studies have been conducted to establish the effect of Semaglutide as a treatment for obesity. This article will summarise a study(1), conducted between January 1, 2021, and March 15, 2022, and assessed how effective is Semaglutide in treating overweight or obese patients, with or without type 2 diabetes, while receiving Semaglutide for up to 6 months. 

    Results 

    A total of 175 patients with a Body Mass Index (BMI) of 27 or more (overweight or obese) who participated in the study were given weekly Semaglutide subcutaneous injections for 3 to 6 months.

    The results of this study revealed that after 3 months of weekly administration of Semaglutide, patients’ weight loss on average was 5.9% and after 6 months of administration of Semaglutide, patients’ weight loss on average was 10.9%. 

    Total Body Weight

    Interestingly, the existence of type 2 diabetes influenced the ability to lose weight. Patients without type 2 diabetes, lost more weight on average. Overall after 3 months of weekly administration of Semaglutide, patients with type 2 diabetes lost on average 3.9% of their body weight and after 6 months of administration of Semaglutide, patients with type 2 diabetes lost on average 6.3% of body weight. Patients without type 2 diabetes showed a greater weight loss on average- which was 6.9% after 3 months of Semaglutide weekly administration and 11.8% after 6 months of Semaglutide weekly administration. 


    Weight Loss by Diabetes Status

    Considering that about 70% of American adults are obese or overweight, this study demonstrated that Semaglutide is a beneficial treatment option. Combined with a weight management program, that includes a reduced calorie diet and increased physical activity, results for weight loss and increased quality of life can be expected. 

     

     

    Reference:

    (1) Ghusn, W. et al, September 19, 2022, Nutrition, Obesity, and Exercise, Weight Loss Outcomes Associated With Semaglutide Treatment for Patients With Overweight or Obesity. 

    • Share:
    Semaglutide Therapy

    You may also like

    Tackle Obesity For Good With Semaglutide Therapy Weight Loss Program

    • March 14, 2023
    • by Semaglutide Therapy
    • in Articles
    Are you ready to lose weight and keep that weight off? Our team takes an integrated approach to help...
    Easily Lose Weight With Semaglutide Therapy!
    March 1, 2023
    Semaglutide Therapy Grows In Demand For Successful Weight Loss Results
    February 15, 2023
    semaglutide weight loss teens
    FDA Approves Semaglutide for Weight Loss in Teens
    January 6, 2023

    Recent Posts

    Tackle Obesity For Good With Semaglutide Therapy Weight Loss Program
    14Mar,2023
    Easily Lose Weight With Semaglutide Therapy!
    01Mar,2023
    Semaglutide Therapy Grows In Demand For Successful Weight Loss Results
    15Feb,2023

    Tags

    semaglutide shortage Semaglutide Therapy Semaglutide therapy for weight loss semaglutide therapy texas semaglutide therapy USA semaglutide weight loss for teens

    Contact Us

    Tel: 1-855-551-1452
    A Renew Life Rx company
    1790 Hughes Landing Blvd #400
    The Woodlands TX 77380

    Newsletters

    Subscribe to get updates right in your inbox. We promise to not send you spams.

    Disclaimer

    The content provided on this website is for informational purposes only. It is not a substitute for professional diagnosis, treatment or medical advice. There is no assurance or warranty regarding the accuracy and applicability of the content. Never ignore professional medical advice in seeking treatment because of something you have read on the website. If you think you may have a medical emergency, immediately call your doctor or emergency service.

    Semaglutide Therapy Designed and Developed by MMS360

    en English
    en Englishes Españolpt Português